Literature DB >> 1594811

Is the 'simple carry-over' model useful?

S J Senn1.   

Abstract

It is argued that the models usually employed for carry-over effects in cross-over trials are not reasonable. The example of a non-linear dose response for a dose-finding trial arranged in a Williams square is developed to show that if carry-over is present to any appreciable degree the usual statistical models provide no guaranteed protection against its effects. It is concluded that the most reasonably defended assumption about carry-over effects is that no important carry-over has taken place and that, where this assumption cannot be defended, statistical models provide no satisfactory substitute for it.

Entities:  

Mesh:

Year:  1992        PMID: 1594811     DOI: 10.1002/sim.4780110603

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers.

Authors:  J Foulds; J Stapleton; J Swettenham; N Bell; K McSorley; M A Russell
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  A note on point estimation and interval estimation of the relative treatment effect under a simple crossover design.

Authors:  Chii-Dean Lin; Kung-Jong Lui
Journal:  Pharm Stat       Date:  2021-11-09       Impact factor: 1.234

3.  Understanding Variation in Sets of N-of-1 Trials.

Authors:  Artur Araujo; Steven Julious; Stephen Senn
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

4.  Blinded and unblinded sample size reestimation in crossover trials balanced for period.

Authors:  Michael J Grayling; Adrian P Mander; James M S Wason
Journal:  Biom J       Date:  2018-08-03       Impact factor: 2.207

5.  The crossover design for migraine preventives: an analyses of four randomized placebo-controlled trials.

Authors:  Astrid Bjørke Jenssen; Lars Jacob Stovner; Erling Tronvik; Trond Sand; Grethe Helde; Gøril Bruvik Gravdahl; Knut Hagen
Journal:  J Headache Pain       Date:  2019-12-27       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.